Last reviewed · How we verify
AdimrSC-2f
At a glance
| Generic name | AdimrSC-2f |
|---|---|
| Sponsor | Adimmune Corporation |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Dose-finding Study for AdimrSC-2f Vaccine (PHASE1, PHASE2)
- A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AdimrSC-2f CI brief — competitive landscape report
- AdimrSC-2f updates RSS · CI watch RSS
- Adimmune Corporation portfolio CI